These findings help us to understand the association and mechanisms of XIAP overexpression with bladder cancer development, they also enable us to explore the utilization of RING domain as a potential therapeutic target for treatment of bladder cancer patients. This evidence concerns the gene XIAP and urinary bladder cancer.